BTIG analysts estimate that Elutia’s Elupro and Medtronic’s TYRX are competing for a $600 million opportunity in the U.S.

Boston Scientific (NYSE: BSX) is scheduled to report its Q1 2023 results on Wednesday, April 26. We expect the company to report revenues and earnings in line with the consensus estimates. A rise in ...

Thermo Fisher Scientific (TMO) just threw a spotlight on its growth ambitions by opening a state-of-the-art, carbon neutral ...

Boston Scientific BSX has solidified its footing as one of three major cardiac device makers and significantly improved its innovation and operational chops. We think the firm’s ability to emerge ...

After two straight years of quarterly sales growth, that trend hasn’t yet gone out of style for Boston Scientific. The medtech giant kicked off its 2023 earnings series Wednesday with a first-quarter ...

OpenAI has launched OpenAI for Science that aims to use ChatGPT-5 as a scientific instrument. The project could accelerate breakthroughs in biology and beyond ...

Boston Scientific successfully continues with its expansion of operations across different geographies outside the United States. In Europe, the Middle East and Africa (EMEA), Boston Scientific is ...

Star Scientific Inc. plans to stop making and selling its dissolvable smokeless tobacco products at the end of the year and instead focus on its dietary supplement business, the company said Monday in ...

Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare ...